期刊文献+

shRNA对A549细胞survivin基因表达及紫杉醇敏感性的影响 被引量:1

Influences of shRNA on survivin gene expression and sensitivity of A549 cells to paclitaxel
下载PDF
导出
摘要 目的观察靶向survivin基因的短发夹RNA(shorthairpin RNA,shRNA)对人肺腺癌细胞A549生物学行为及紫杉醇敏感性的影响。方法将靶向survivin的基因片段插入载体后构建重组质粒,用转染试剂FuGENE(HD将其导入A549细胞,RT-PCR及Western blot分析转染前后survivin基因的表达情况,TUNEL法检测细胞凋亡情况,MTT法检测转染后A549细胞对紫杉醇的敏感性变化。结果成功构建重组质粒。与对照组相比,转染重组质粒后,survivin基因的表达明显降低,细胞凋亡率增加。转染前紫杉醇抑制A549细胞的IC50为转染后的11.9倍,两者比较,差异有显著性(P<0.05)。结论靶向survivin的shRNA能下调survivin基因表达,诱导细胞凋亡,增强A549细胞对紫杉醇的敏感性。 Aim To construct the eukaryotic expression vectors of short hairpin RNA targeting survivin and observe its effect on biologic behavior of A549 cells and sensitivity of A549 cells to paclitaxel. Methods The DNA fragment targeting human survivin was inserted into the plasmid, and the recombinant plasmid was constructed. The recombinant plasmids cells were transfected into A549 cells by FuGENE transfection reagent. The expression levels of survivin gene were detected with RT-PCR and Western blot before and after transfection, respectively. Cell apoptosis was detected by TUNEL method. The sensitivity of A549 cells to paclitaxel was detected by MTT after transfection. Results The recombinant plasmid was successfully constructed. RNAi group cells showed lower expression of survivin than control group. The apoptosis rate of A549 cells increased after transfection. The IC50 of paclitaxel inhibiting A549 cells was 11.9 fold before transfection compared with those after transfection. There was significant difference between the two groups (P 〈 0. 05 ). Conclusion The shRNA targeting human survivin can down-regulate the expression of survivin, induce apoptosis, and enhance the sensitivity of A549 cells to paclitaxel.
出处 《中国药理学通报》 CAS CSCD 北大核心 2009年第5期589-592,共4页 Chinese Pharmacological Bulletin
基金 山东省自然科学基金青年基金资助项目(NoQ2006D08)
关键词 SHRNA SURVIVIN 紫杉醇 肺腺癌细胞 shRNA survivin paclitaxel lung adenocarcinoma cells
  • 相关文献

参考文献12

二级参考文献48

共引文献42

同被引文献10

  • 1Costello E, Greenhalf W, Neoptolemos J P. New biomarkers and targets in pancreatic cancer and their application to treatment [ J]. Nat Rev Gastroenterol Hepatol, 2012,9(8) :435 -44. 被引量:1
  • 2Long J, Zhang Y, Yu X, et al. Overcoming drug resistance in pancreatic cancer[ J ]. Expert Opin Ther Targets, 2011,15 (7) :817 -28. 被引量:1
  • 3Galante J M, Mortenson M M, Bowles T L, et al. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis [ J ]. J Surg Res, 2009,152 ( 1 ) : 18 - 25. 被引量:1
  • 4Mita A C, Mira M M, Nawrocki S T, et al. Survivin : key regula- tor of mitosis and apoptosis and novel target for cancer therapeutics [J]. Clin Cancer Res, 2008,14:5000 -5. 被引量:1
  • 5Kunze D, Erdmann K, Froehner M, et al. siRNA-mediated inhi- bition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells [ J ]. Anticancer Res, 2012,32 ( 10 ) :4313 - 8. 被引量:1
  • 6Lu Y, Li C S, Dong Q. Chinese herb related molecules of cancer- cell-apoptosis : a minireview of progress between Kanglaite injection and related genes[ J ]. J Exp Clin Cancer Res ,200g ,27:31 -5. 被引量:1
  • 7Holcomb B, Yip-Schneider M, Schmidt C M. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy [J]. Pancreas, 2008,36(3) :225 -35. 被引量:1
  • 8李大鹏.康莱特注射液药效学及临床研究进展[J].中国新药与临床杂志,2007,26(10):778-782. 被引量:39
  • 9孟金兰,董艳芬,莫利求,杨春涛,兰爱平,杨战利,陈培熹,冯鉴强.Survivin在PC12细胞对抗化学性缺氧损伤中的作用[J].中国药理学通报,2010,26(4):526-530. 被引量:5
  • 10沈伟生,舒中琴,邓立春,曹向明,奚蕾,张瑶,曾洁,盛华明,高春恒.康莱特联合吉西他滨三维适形同步放化疗治疗局部晚期胰腺癌临床观察[J].中国中西医结合杂志,2012,32(7):902-905. 被引量:16

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部